molybdenum-cofactor and Nervous-System-Diseases

molybdenum-cofactor has been researched along with Nervous-System-Diseases* in 4 studies

Reviews

1 review(s) available for molybdenum-cofactor and Nervous-System-Diseases

ArticleYear
Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.
    Annual review of biochemistry, 1985, Volume: 54

    Topics: Alcohol Oxidoreductases; Animals; Biopterins; Body Fluids; Coenzymes; GTP Cyclohydrolase; Humans; Immune System Diseases; Mental Disorders; Metalloproteins; Molybdenum; Molybdenum Cofactors; Neoplasms; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines; Pterins; Tetrahydrofolate Dehydrogenase; Tissue Distribution; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase

1985

Other Studies

3 other study(ies) available for molybdenum-cofactor and Nervous-System-Diseases

ArticleYear
Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor.
    Journal of inherited metabolic disease, 1996, Volume: 19, Issue:5

    Topics: Coenzymes; Female; Fibroblasts; Humans; Hypoxanthine; Infant; Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines

1996
Molybdenum cofactor deficiency associated with Dandy-Walker malformation.
    Journal of inherited metabolic disease, 1995, Volume: 18, Issue:1

    Topics: Coenzymes; Dandy-Walker Syndrome; Humans; Infant, Newborn; Kidney Calculi; Lens Subluxation; Male; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Pteridines; Ultrasonography

1995
Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor.
    Proceedings of the National Academy of Sciences of the United States of America, 1980, Volume: 77, Issue:6

    A patient suffering from a combined deficiency of sulfite oxidase (sulfite dehydrogenase; sulfite:ferricytochrome c oxidoreductase, EC 1.8.2.1) and xanthine dehydrogenase (xanthine:NAD+ oxidoreductase, EC 1.2.1.37) is described. The patient displays severe neurological abnormalities, dislocated ocular lenses, and mental retardation. Urinary excretion of sulfite, thiosulfate, S-sulfocysteine, taurine, hypoxanthine, and xanthine is increased in this individual, while sulfate and urate levels are drastically reduced. The metabolic defect responsible for loss of both enzyme activities appears to be at the level of the molybdenum cofactor common to the two enzymes. Immunological examination of a biopsy sample of liver tissue revealed the presence of the xanthine dehydrogenase protein in near normal amounts. Sulfite oxidase apoprotein was not detected by a variety of immunological techniques. The plasma molybdenum concentration was normal; however, hepatic content of molybdenum and the storage pool of active molybdenum cofactor present in normal livers were below the limits of detection. Fibroblasts cultured from this patient failed to express sulfite oxidase protein or activity, whereas those from the parents and healthy brother of the patient expressed normal levels of this enzyme.

    Topics: Child, Preschool; Coenzymes; Female; Fibroblasts; Humans; Immunologic Techniques; Intellectual Disability; Ketone Oxidoreductases; Lens Subluxation; Liver; Metal Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Xanthine Dehydrogenase

1980